相关实验视频

Updated: Mar 10, 2026

High-Efficiency Transduction of Liver Cancer Cells by Recombinant Adeno-Associated Virus Serotype 3 Vectors

High-Efficiency Transduction of Liver Cancer Cells by Recombinant Adeno-Associated Virus Serotype 3 Vectors

Published on: March 22, 2011

整体素αvβ3是胆管癌中潜在的治疗点

Fitria Sari Wulandari^1,2, Chih-Yang Wang^1,3, Dana R Crawford⁴

¹Graduate Institute of Cancer Molecular Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, Taipei 11031, Taiwan.

International journal of medical sciences

|March 9, 2026

概括

甲状腺素的类似物tetraiodothyronine (tetrac) 通过向整合素αvβ3.3来抑制癌症的生长. 这种新的策略显示了通过阻断癌细胞增殖和转移来治疗胆管癌的潜力.

科学领域:

在瘤学瘤学.
分子生物学分子生物学
细胞生物学细胞生物学

背景情况:

整体素αvβ3是一种细胞表面受体,在癌症中过度表达,促进瘤生长和转移.
甲状腺激素和表皮生长因子 (EGF) 与整合素αvβ3相互作用,影响癌细胞信号传递和增殖.
甲状腺素 (T4) 类似物,四甲状腺素 (tetrac),抑制整合素αvβ3结合,表明治疗潜力.

研究的目的:

研究整合素αvβ3在胆管癌中的致病作用.
探索用四衍生物向整合素αvβ3的治疗潜力.

主要方法:

对临床胆管癌样本的分析,以研究整合素αvβ3相互作用.
研究了甲状腺素和EGF对PD-L1表达和信号通路的影响.
评估了Lipo-tetrac及其Dox衍生物在体外和异种移植模型中的抗增殖作用.

主要成果:

整体素αvβ3与EGFR和甲状腺激素/EGF信号通路在胆管癌进展中的交叉.
甲状腺素和EGF刺激PD-L1表达,促进癌症生长;甲状腺素诱导的PD-L1定位在细胞核中,而EGF诱导的PD-L1影响细胞和核通路.
向整合素αvβ3与脂四和其Dox衍生物的向显示出显著的抗增殖作用.

结论:

综合素αvβ3通过与生长因子和信号网络的相互作用,在胆管癌的发病过程中发挥着关键作用.
泰特拉克及其衍生品通过抑制整体素αvβ3.3来代表胆管癌的有前途的治疗策略.
这项研究为开发针对胆管癌的新型向治疗提供了基础.

关键词:

胆瘤是一种胆瘤.皮肤表皮生长因子皮肤上生长因子受体 (EGFR)整体中的αvβ3β3 纳米四子是如何使用的编程死亡连接体1 (PD-L1) 编程死亡连接体甲状腺素甲状腺素

更多相关视频

Portal Vein Injection of Colorectal Cancer Organoids to Study the Liver Metastasis Stroma

Portal Vein Injection of Colorectal Cancer Organoids to Study the Liver Metastasis Stroma

Published on: September 3, 2021

Intraoperative Strategy under Complex Vascular Adhesion for Laparoscopic Radical Resection of Bismuth-Corlette Type IIIb Perihilar Cholangiocarcinoma

Intraoperative Strategy under Complex Vascular Adhesion for Laparoscopic Radical Resection of Bismuth-Corlette Type IIIb Perihilar Cholangiocarcinoma

Published on: February 13, 2026

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Intracellular Signaling Affects Focal Adhesions

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...

Activation of Integrins

Activation of Integrins

Integrins bind ligands and transmit information from outside the cell to inside or vice-versa through an "outside-in signaling" or "inside-out signaling."
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding...